+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bovine Mastitis Market - Global Forecast 2026-2032- Product Image
Bovine Mastitis Market - Global Forecast 2026-2032- Product Image
New

Bovine Mastitis Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 186 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6084136
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Bovine mastitis remains a critical concern for dairy production worldwide, driving continued transformation in disease management through evolving technologies, regulations, and commercial practices. Senior decision-makers in animal health must now navigate complex supply chains, stewardship imperatives, and shifting market dynamics to optimize herd performance and operational resilience.

Market Snapshot: Bovine Mastitis Market Growth and Outlook

The Bovine Mastitis Market grew from USD 1.57 billion in 2025 to USD 1.67 billion in 2026. It is expected to continue growing at a CAGR of 6.04%, reaching USD 2.36 billion by 2032. This expansion reflects not only an increased focus on animal health but also the integration of advanced diagnostics, heightened regulatory oversight, and rising producer investment in both prevention and therapeutics. Growing supply chain adaptability supports evolving distribution models across established and emerging markets.

Scope & Segmentation of the Bovine Mastitis Market

  • Product Types: Antibiotics (including aminoglycosides, beta-lactams, tetracyclines; beta-lactams comprise cephalosporins and penicillins), Teat Sealants, Vaccines
  • Clinical Applications: Dry Cow Therapy and Lactation Therapy
  • Distribution Channels: Direct Sales, Distributors, Online Channels
  • End Users: Dairy Farms, Veterinary Clinics
  • Administration Routes: Intramammary, Parenteral
  • Dosage Forms: Ointment, Powder, Solution
  • Regional Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific

Technological adoption in diagnostics such as rapid molecular assays, combined with stewardship-guided protocols, is increasingly central to commercial and clinical strategies. Regionally, the market is shaped by differences in regulatory stringency, farm structure diversity, and public-private collaboration.

Bovine Mastitis Market: Key Takeaways

  • Scientific advances in pathogen detection and treatment decision tools are driving a shift to evidence-based mastitis control, emphasizing animal welfare and operational efficiency.
  • Antimicrobial stewardship is reshaping product selection, promoting targeted therapies and alternatives to routine broad-spectrum antibiotic use, especially during dry-off periods.
  • Supply chain strategies are focusing on local sourcing, redundancy, and direct-to-farm models to maintain accessibility and manage pricing volatility.
  • Stakeholder roles are broadening—from manufacturers to distributors and veterinarians—to support bundled solutions that combine therapeutics, diagnostics, and ongoing guidance.
  • Adoption patterns and investment priorities vary by region due to regulatory differences, market consolidation, and diverse end-user needs, particularly between intensive and smaller-scale operations.

Impact of 2025 United States Tariff Measures

Recent United States tariff changes have impacted the veterinary pharmaceutical supply chain, influencing sourcing strategies and cost structures for mastitis therapeutics and diagnostics. Companies are diversifying manufacturing and procurement pathways, and end users are responding with more deliberate purchasing and greater reliance on veterinary advisement to maximize value per treatment. These changes are accelerating broader conversations on supply resilience and transparent sourcing.

Methodology & Data Sources

Findings are based on structured interviews with veterinarians, producers, and supply chain experts, complemented by analysis of regulatory documents and peer-reviewed studies. Cross-validation with multiple independent data sources and iterative expert review underpin the report’s operational and clinical rigor. Qualitative insights contextualize quantitative trends to ensure relevance for practitioners and decision-makers.

Bovine Mastitis Market: Why This Report Matters

  • Provides an integrated view of market drivers and segment-specific opportunities tailored for decision-makers shaping animal health strategies.
  • Offers regionally nuanced analysis of technology adoption, regulatory dynamics, and evolving distribution models crucial for strategic planning.
  • Supports prioritization of investments in diagnostics, stewardship-aligned therapeutics, and resilient supply chain initiatives for sustainable mastitis management.

Conclusion

Senior leaders seeking to optimize herd health, operational efficiency, and compliance will find practical, expert-driven insights in the evolving bovine mastitis market landscape. Ongoing collaboration and proactive adoption of integrated diagnostics and stewardship protocols will help convert innovation into tangible benefits for producers and industry stakeholders.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Bovine Mastitis Market, by Product Type
8.1. Antibiotics
8.1.1. Aminoglycosides
8.1.2. Beta Lactams
8.1.2.1. Cephalosporins
8.1.2.2. Penicillins
8.1.3. Tetracyclines
8.2. Teat Sealants
8.3. Vaccines
9. Bovine Mastitis Market, by Route Of Administration
9.1. Intramammary
9.2. Parenteral
10. Bovine Mastitis Market, by Dosage Form
10.1. Ointment
10.2. Powder
10.3. Solution
11. Bovine Mastitis Market, by Application
11.1. Dry Cow Therapy
11.2. Lactation Therapy
12. Bovine Mastitis Market, by Distribution Channel
12.1. Direct Sales
12.2. Distributors
12.3. Online Channels
13. Bovine Mastitis Market, by End User
13.1. Dairy Farms
13.2. Veterinary Clinics
14. Bovine Mastitis Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Bovine Mastitis Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Bovine Mastitis Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Bovine Mastitis Market
18. China Bovine Mastitis Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Boehringer Ingelheim International GmbH
19.6. Ceva Santé Animale S.A.
19.7. Elanco Animal Health Incorporated
19.8. HIPRA, S.A.
19.9. Huvepharma NV
19.10. IDEXX Laboratories, Inc.
19.11. Merck & Co., Inc.
19.12. Phibro Animal Health Corporation
19.13. Vetoquinol S.A.
19.14. West Way Health
19.15. Zoetis Inc.
List of Figures
FIGURE 1. GLOBAL BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BOVINE MASTITIS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BOVINE MASTITIS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BOVINE MASTITIS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BOVINE MASTITIS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BOVINE MASTITIS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BOVINE MASTITIS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BOVINE MASTITIS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BOVINE MASTITIS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BOVINE MASTITIS MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BOVINE MASTITIS MARKET SIZE, BY CEPHALOSPORINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BOVINE MASTITIS MARKET SIZE, BY CEPHALOSPORINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TEAT SEALANTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TEAT SEALANTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BOVINE MASTITIS MARKET SIZE, BY TEAT SEALANTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BOVINE MASTITIS MARKET SIZE, BY INTRAMAMMARY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BOVINE MASTITIS MARKET SIZE, BY INTRAMAMMARY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BOVINE MASTITIS MARKET SIZE, BY INTRAMAMMARY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PARENTERAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BOVINE MASTITIS MARKET SIZE, BY PARENTERAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BOVINE MASTITIS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BOVINE MASTITIS MARKET SIZE, BY OINTMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BOVINE MASTITIS MARKET SIZE, BY OINTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BOVINE MASTITIS MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BOVINE MASTITIS MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BOVINE MASTITIS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BOVINE MASTITIS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BOVINE MASTITIS MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BOVINE MASTITIS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DRY COW THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DRY COW THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DRY COW THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BOVINE MASTITIS MARKET SIZE, BY LACTATION THERAPY, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BOVINE MASTITIS MARKET SIZE, BY LACTATION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BOVINE MASTITIS MARKET SIZE, BY LACTATION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ONLINE CHANNELS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BOVINE MASTITIS MARKET SIZE, BY ONLINE CHANNELS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DAIRY FARMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BOVINE MASTITIS MARKET SIZE, BY DAIRY FARMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VETERINARY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BOVINE MASTITIS MARKET SIZE, BY VETERINARY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BOVINE MASTITIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS BOVINE MASTITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 76. AMERICAS BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 77. AMERICAS BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 83. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 84. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 85. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 86. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 90. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 91. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 92. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 93. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 94. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 95. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 96. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. LATIN AMERICA BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. EUROPE BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. EUROPE BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 109. EUROPE BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 110. EUROPE BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 111. EUROPE BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 112. EUROPE BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 113. EUROPE BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 115. EUROPE BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 118. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 119. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 120. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 121. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 122. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 123. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 124. MIDDLE EAST BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. AFRICA BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. AFRICA BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. AFRICA BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 128. AFRICA BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 129. AFRICA BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. AFRICA BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 131. AFRICA BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. AFRICA BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. AFRICA BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 136. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 137. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 138. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 139. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 140. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BOVINE MASTITIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 144. ASEAN BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 145. ASEAN BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 146. ASEAN BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 147. ASEAN BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 148. ASEAN BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 149. ASEAN BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 150. ASEAN BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. ASEAN BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 152. ASEAN BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. GCC BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GCC BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 155. GCC BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 156. GCC BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 157. GCC BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. GCC BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 159. GCC BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. GCC BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. GCC BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. BRICS BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. BRICS BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. BRICS BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 174. BRICS BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 175. BRICS BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 176. BRICS BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 177. BRICS BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 178. BRICS BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 179. BRICS BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. G7 BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. G7 BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 182. G7 BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 183. G7 BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 184. G7 BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. G7 BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 186. G7 BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 187. G7 BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 188. G7 BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. NATO BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. NATO BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 191. NATO BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 192. NATO BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 193. NATO BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 194. NATO BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 195. NATO BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 196. NATO BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 197. NATO BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL BOVINE MASTITIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 207. UNITED STATES BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 208. CHINA BOVINE MASTITIS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 209. CHINA BOVINE MASTITIS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 210. CHINA BOVINE MASTITIS MARKET SIZE, BY ANTIBIOTICS, 2018-2032 (USD MILLION)
TABLE 211. CHINA BOVINE MASTITIS MARKET SIZE, BY BETA LACTAMS, 2018-2032 (USD MILLION)
TABLE 212. CHINA BOVINE MASTITIS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 213. CHINA BOVINE MASTITIS MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 214. CHINA BOVINE MASTITIS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. CHINA BOVINE MASTITIS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 216. CHINA BOVINE MASTITIS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Elanco Animal Health Incorporated
  • HIPRA, S.A.
  • Huvepharma NV
  • IDEXX Laboratories, Inc.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • West Way Health
  • Zoetis Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.67 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.36 Billion
Compound Annual Growth Rate6.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bovine Mastitis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Bovine Mastitis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Bovine Mastitis Treatment System - Global Strategic Business Report - Product Image

Bovine Mastitis Treatment System - Global Strategic Business Report

  • Report
  • 366 Pages
  • Global
From
Elsevier's Review for the NAVLE, 1st Edition - Product Image

Elsevier's Review for the NAVLE, 1st Edition

  • Book
Bovine Treatment Systems - Global Strategic Business Report - Product Image

Bovine Treatment Systems - Global Strategic Business Report

  • Report
  • 181 Pages
  • Global
From
Bovine Respiratory Disease Treatment Market - Global Forecast 2026-2032 - Product Image

Bovine Respiratory Disease Treatment Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From

About the Bovine Mastitis Drug Market

Bovine Mastitis Drug is a type of animal pharmaceutical used to treat mastitis, an inflammation of the mammary glands in cows. It is a common and costly disease in dairy herds, and can lead to decreased milk production, increased culling, and increased veterinary costs. Bovine Mastitis Drugs are typically administered intramammary, and can be either systemic or topical. Systemic drugs are absorbed into the bloodstream and distributed throughout the body, while topical drugs are applied directly to the affected area. Common active ingredients in Bovine Mastitis Drugs include antibiotics, anti-inflammatory agents, and antifungals. Some companies in the Bovine Mastitis Drug market include Elanco, Merck Animal Health, Zoetis, Boehringer Ingelheim, and Bayer Animal Health. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.